888639

Cumberland Pharmaceuticals, Inc. — FEI 3003258245

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 25, 2014
Fiscal Year
2014
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Nashville, TN (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)